6533b829fe1ef96bd128af3e
RESEARCH PRODUCT
NDM-1-producing Acinetobacter baumannii ST85 now in Turkey, including one isolate from a Syrian refugee.
Fatih KöksalCaterina MamminaFarzad Heydarisubject
Microbiology (medical)Acinetobacter baumanniiTurkeyRefugeeMicrobiologybeta-LactamasesMicrobiologyAcinetobacter infectionsDrug Resistance Multiple BacterialPulsed-field gel electrophoresisMedicineHumansAgedRefugeesbiologySyriabusiness.industryGeneral MedicineMiddle Agedbiology.organism_classificationAcinetobacter baumanniiAnti-Bacterial AgentsClonal relationshipMultilocus sequence typingNew delhiFemalebusinessAcinetobacter Infectionsdescription
PubMedID: 26296677 New Delhi metallo-b-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat owing to the extended hydrolysis of ß-lactams including carbapenems. Here, to the best of our knowledge we describe for the first time in Turkey two NDM-1- producing Acinetobacter baumannii isolates recovered from intensive care unit patients. The presence of blaNDM-1 was detected by PCR and confirmed by sequencing. The clonal relationship was assessed by PFGE and multilocus sequence typing. Both isolates were positive for blaNDM-1 and were attributed with the sequence type 85. One isolate was from a Syrian refugee, whereas the second was from a patient who had never travelled outside Turkey. Our findings confirmed that the rapid spread of NDM-1-producing Gram-negative organisms could become a major challenge for the treatment and control of healthcare-associated infections in our geographical area. They suggest also that NDM-1-producing strains and/or their genetic determinants are probably being imported from Syria to neighbouring countries. © 2015 SGM.
year | journal | country | edition | language |
---|---|---|---|---|
2015-08-23 | Journal of medical microbiology |